VAQTA is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Hepatitis A Virus Strain Cr 326f Antigen (formaldehyde Inactivated).
Product ID | 0006-4841_22da7280-40e2-44b4-9a13-c3a8907c1f46 |
NDC | 0006-4841 |
Product Type | Vaccine |
Proprietary Name | VAQTA |
Generic Name | Hepatitis A Vaccine, Inactivated |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 1996-03-29 |
Marketing Category | BLA / BLA |
Application Number | BLA103606 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) |
Active Ingredient Strength | 50 [iU]/mL |
Pharm Classes | Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 1996-03-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103606 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 1996-03-29 |
Marketing Category | BLA |
Application Number | BLA103606 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 1996-03-29 |
Marketing Category | BLA |
Application Number | BLA103606 |
Product Type | VACCINE |
Billing Unit | ML |
Marketing Start Date | 1996-03-29 |
Ingredient | Strength |
---|---|
HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) | 50 [iU]/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0006-4095 | VAQTA | hepatitis A vaccine, inactivated |
0006-4096 | VAQTA | hepatitis A vaccine, inactivated |
0006-4831 | VAQTA | hepatitis A vaccine, inactivated |
0006-4841 | VAQTA | hepatitis A vaccine, inactivated |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VAQTA 74279657 1874483 Live/Registered |
MERCK SHARP & DOHME CORP. 1992-05-29 |